spacer
home > ict > spring 2019 > enhancing the patient experience
PUBLICATIONS
International Clinical Trials

Enhancing the Patient Experience

The opportunities to strengthen patient engagement across all phases of clinical development have never been greater. We can now apply technology in creative ways to collect meaningful data from patients without increasing their burden as trial participants.

At the same time, empowered patients have high expectations of their health-related experiences in general, with clinical trial participation being no exception. As savvy consumers, patients expect technology to be both easy and enjoyable to use. Therefore, study sponsors and CROs should look to take advantage of the latest tools to ensure that a patientís involvement meets their expectations, fits into their daily lives to the greatest extent possible, and is, overall, a rewarding experience.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
James Munz is a product expert who has been solving business problems with cutting edge analytical and technical solutions for close to 20 years. As Vice President of eCOA Product Management, James is responsible for building and executing ERTís market-driven strategy for the eCOA product line. Prior to ERT, he was Vice President of Product at Opera Solutions where he was responsible for the development of a Big Data analytics platform used across supply chain, financial services, marketing, healthcare, and telecommunications industries. Additionally, he led one of the first products to leverage the Amazon Cloud.

Chris Watson PhD is a Product Strategist with 20 yearsí experience in the delivery of business and consumer-based solutions, the last 10 of which have been within the clinical technology industry. He has extensive knowledge of product and software development processes and is responsible for implementing the product strategy for ERTís digital patient business. Chris earned his PhD in Behavioural Neurosciences from the University of Nottingham, UK, and a BSc in pharmacology and toxicology, with honours, from the University of Bradford, UK.
spacer
James Munz
spacer
spacer
spacer
Chris Watson PhD
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals enters into manufacturing agreement with the Swedish company Affibody

[NoŠin, May 27, 2019] 3P Biopharmaceuticals, a leading CDMO specialized in the process development and GMP manufacturing of biologics, has signed a collaboration agreement with the Swedish company Affibody for the process transfer, scale-up and GMP commercial manufacturing of a recombinant protein sole property of Affibody.
More info >>

White Papers

Soothing the Logistical Headache of Clinical Trials

Equilibrium Travel Management

As many as 30 per cent of subjects on phase three clinical studies drop out.  Gruelling schedules, high travel costs and time waiting for expense reimbursement can all be factors in these fall rates, and this can be very problematic, delaying or even leading to the cancellation of the trial.  It is crucial to keep subjects motivated, and through efficient travel and expense management, this can be achieved.
More info >>

 
Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement